Controlled release oral drug delivery system
US7189414B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Jul 31, 2003 |
| Grant date | Mar 13, 2007 |
| Priority date | — |
| Expiry date | Aug 29, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2013
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to synchronous drug delivery composition comprising a polymeric matrix which comprises hydrogel blended with a hydrophobic polymer, so as to form an erodible matrix, a drug, and, optionally, an agent which enhances intestinal drug absorption and/or an agent which inhibits intestinal drug degradation,wherein erosion of the erodible matrix, permits synchronous release of the drug, the hydrogel and the intestinal drug absorption agent and/or the agent which inhibits intestinal drug degradation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.